PR

Pratik Rajendra Pawar

Active Director Director DIN 11486196
DIN 11486196 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pratik Rajendra Pawar

Data last updated:

Pratik Rajendra Pawar is a Director at Ronyx Pharmaceutical Private Limited (since 2026).

DIN 11486196
Primary Designation Director
First Appointment 15 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ronyx Pharmaceutical Private Limited U46497MH2026PTC465821
Director15 Jan 20262026Active

Board colleagues of Pratik Rajendra Pawar

NameDINCompanyDesignation
Renuka Madhavarao Gadekar10244369Ronyx Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ronyx Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Pratik Rajendra Pawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pratik Rajendra Pawar

Pratik Rajendra Pawar currently holds 1 directorship: Ronyx Pharmaceutical Private Limited (Director, since 15 Jan 2026).

Pratik Rajendra Pawar was first appointed on 15 Jan 2026 as Director at Ronyx Pharmaceutical Private Limited.

The current boards of Pratik Rajendra Pawar's companies include Renuka Madhavarao Gadekar (Ronyx Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available